CCL17 and glioblastoma: On the other hand, the expression of CCL17 and CCL22 is elevated in a breast cancer tumor [100], CCL22 expression is increased in colorectal adenocarcinomas [213], while CCL17 expression is increased in glioblastoma multiforme [101].